Cargando…
Prognostic implications of cellular senescence in resected non-small cell lung cancer
BACKGROUND: Cure and long-term survival for non-small cell lung cancer (NSCLC) remains hard to achieve. Cellular senescence, an emerging hallmark of cancer, is considered as an endogenous tumor suppressor mechanism. However, senescent cancer cells can paradoxically affect the surrounding tumor micro...
Autores principales: | Domen, Andreas, Deben, Christophe, De Pauw, Ines, Hermans, Christophe, Lambrechts, Hilde, Verswyvel, Jasper, Siozopoulou, Vasiliki, Pauwels, Patrick, Demaria, Marco, van de Wiel, Mick, Janssens, Annelies, Hendriks, Jeroen M. H., Van Schil, Paul, Vermorken, Jan B., Vandamme, Timon, Prenen, Hans, Peeters, Marc, Lardon, Filip, Wouters, An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459607/ https://www.ncbi.nlm.nih.gov/pubmed/36090630 http://dx.doi.org/10.21037/tlcr-22-192 |
Ejemplares similares
-
Cellular senescence in cancer: clinical detection and prognostic implications
por: Domen, Andreas, et al.
Publicado: (2022) -
In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53
por: Van den Bossche, Jolien, et al.
Publicado: (2019) -
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer
por: Domen, Andreas, et al.
Publicado: (2021) -
Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia
por: Van den Bossche, Jolien, et al.
Publicado: (2017) -
Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status
por: Van den Bossche, Jolien, et al.
Publicado: (2019)